|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Aug―23 |
Incidence and severity of COVID-19 among HIV positive patients with existing co-morbidities |
Raphael Mwamtsi Lwembe, Joseph Newton Guni, Mary Muyeku, Lihana Wekesa, Joseph Muriuki, Joseph Mwangi, et al. (+9) Alex Maiyo, Judy Chege, Joyceline Kinyua, Dama Olungae, Rency lel, Nancy Lagat, Collins Okoyo, Edward K Maina, Khamadi Ashimosi |
2 |
[GO] |
2024―May―23 |
Covid-19: Lessons from the pandemic in sub-Saharan Africa relevant to the WHO IA2030 vaccination agenda |
Andrew Macnab |
3 |
[GO] |
2024―Feb―07 |
COVID-19 current scenario |
LP Awasthi, HN Verma |
4 |
[GO] |
2024―Feb―07 |
Salivary Coronavirus Infection Therapy With Potential Soluble Angiotensin-Converting Enzyme 2 |
Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn, Porntep Siriwanarangsun |
5 |
[GO] |
2023―Aug―29 |
Antibody response after booster vaccination after SARS-CoV-2 breakthrough infections in patients with advanced cancer |
Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn, Porntep Siriwanarangsun |
6 |
[GO] |
2023―Aug―11 |
Humoral and cellular immune response in kidney transplant recipients after COVID-19 vaccination |
Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn, Porntep Siriwanarangsun |
7 |
[GO] |
2023―Jun―26 |
Designing of pan-coronavirus fusion inhibitors and vaccines with targetable elements in SARS-CoV-2 S2 subunit |
Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn, Porntep Siriwanarangsun |
8 |
[GO] |
2023―May―06 |
COVID-19 vaccine induced t-cell immunity influenced by age and comorbidities |
Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn, Porntep Siriwanarangsun |
9 |
[GO] |
2023―Apr―15 |
Emerging coronavirus and characteristics: A minireview |
Sahrish Khan, Abida Bibi |
10 |
[GO] |
2023―Apr―15 |
The epidemiology of Coronavirus SARS Cov-2 virus in Iran |
Houshang Jamali, Mohamad Reza Jafari |
11 |
[GO] |
2023―Apr―15 |
A review of contagious Coronavirus (SARS-Cov-2) their clinical features, diagnosis, preventions and treatment |
Mukesh Meena, Prashant Swapnil |
12 |
[GO] |
2023―Apr―15 |
Automation of the RT-PCR to detect SARS-CoV-2 approved in Mexico by using the BD Max open system |
Becerril Vargas Eduardo, Antonio-Juárez Etzael, Martínez-Orozco José Arturo, Sánchez-Tinajero Ángel, Delgado-Cueva Andrea Iraís, Prieto-Padilla Javier, et al. (+5) Larios-Mondragón Lina, Rodríguez- Sánchez Víctor Manuel, Valencia-Trujillo Daniel, García-Colín María del Carmen, Mujica-Sánchez Mario |
13 |
[GO] |
2023―Apr―15 |
The COVID-19 syndemic |
Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn, Porntep Siriwanarangsun |
14 |
[GO] |
2023―Apr―15 |
Recovery of COVID-19 in a patient with recent diagnosis of HIV infection |
Sandra R Delgado |
15 |
[GO] |
2023―Apr―15 |
Povidone iodine as a low cost therapeutic against the SARS-CoV-2 virus and its potential for refugee health |
Cameron L Jones |
16 |
[GO] |
2023―Apr―01 |
A Personalized and precision medicine framework in the treatment of pre-existing conditions in coronavirus disease |
Ewaoche Sunday Itodo, Yibala Ibor oboma, Tolulope Alade |
17 |
[GO] |
2023―Mar―25 |
Comprehensive review on the evolution of SARS-CoV-2(COVID-19): From emergence, outbreak,molecular characterization to the clinical challenges in designing and developing potential drugs, vaccines and therapies to counter SARSCoV-2 |
Pallabi Banerjee, Tripti Singh, Nagendra Singh, Imteyaz Qamar |
18 |
[GO] |
2023―Mar―25 |
Pathogenesis and pulmonary pathology of covid-19 |
Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn |
19 |
[GO] |
2023―Mar―25 |
Recovery from Covid-19 and evolution, 03.22.2020 |
Daniel Benharroch, Yane-Bianca Benharroch, Ilai Goshen |
20 |
[GO] |
2023―Mar―14 |
SARS-CoV-2 (COVID-19) infection in patients with HTLV-1 infection in Peru - case series |
Eduardo Gotuzzo, Jorge Nakazaki, Fernando Mejía, Martin Montes |
21 |
[GO] |
2023―Feb―27 |
Potential SARS-CoV-2 (COVID-19) Carrier by PM2.5 |
Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn, Porntep Siriwanarangsun |
22 |
[GO] |
2023―Feb―06 |
Severe and non-severe Covid-19 patients with postintubation tracheal stenosis |
Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn, Porntep Siriwanarangsun |
23 |
[GO] |
2023―Feb―04 |
SARS-CoV-2 (COVID-19) vaccination, affected on post-acute-COVID-19-sequelae symptoms (long COVID-19) |
Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn, Porntep Siriwanarangsun |
24 |
[GO] |
2023―Feb―04 |
Imaging and histological approach to the diagnosis of pulmonary lesions by COVID-19: case report |
Jose Cabrales Fuentes, Susana Verdecia Barbie, Alejandro Luis Mendoza Cabalé |
25 |
[GO] |
2023―Feb―04 |
Severe and non-severe Covid-19 patients with postintubation tracheal stenosis |
Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn, Porntep Siriwanarangsun |
26 |
[GO] |
2023―Feb―04 |
Interaction of dermal filler and COVID-19’s mRNA vaccine |
Poorya Davoodi, Atousa Hashemi, Noushin Yazdanpanahi Dehnavi, Negin Ahmadfakhredin, Melika Jourablou, Nima Fouladi Ghareshiran |
27 |
[GO] |
2023―Feb―04 |
Computational method in COVID-19: Revelation of preliminary mutations of RdRp of SARS CoV-2 that build new horizons for therapeutic development |
Fareeda Athar, Md Amjad Beg |
28 |
[GO] |
2023―Feb―04 |
Covid 19: health promotion strategies suited to further global containment of the pandemic |
Andrew Macnab |
29 |
[GO] |
2022―Dec―21 |
Azole derivatives inhibit the binding of the RBD domain of SARS-Cov-2 against host ACE2 in in vitro assays |
Katiusca Villasana, Balbino Perdomo, Leonardo Dugarte, Geizon Torres, José Manuel Pujol |
30 |
[GO] |
2020―Jun―11 |
Clinical characteristics of Covid-19 cases in Guayaquil, Ecuador |
Mariolga Bravo-Acosta, Paola Vélez-Solorzano, Dilia Martínez- Méndez |
31 |
[GO] |
2020―Jun―11 |
Environmental surface contamination with SARS-CoV-2 - a short review |
Cameron L Jones |